Document Detail

Regional oral absorption, hepatic first-pass effect, and non-linear disposition of salmon calcitonin in beagle dogs.
MedLine Citation:
PMID:  10962228     Owner:  NLM     Status:  MEDLINE    
The dose-dependent disposition, first pass hepatic elimination, and absorption pharmacokinetics (PK) of salmon calcitonin (sCT) were investigated in a canine Intestinal Vascular Access Port (IVAP) model. The PK of sCT were determined after intravenous (IV), subcutaneous (SC), portal venous (PV), and oral (PO) administration of sCT. Regional oral absorption of unformulated sCT was also evaluated by direct administration into the duodenum (ID), ileum (IL), and colon (IC) by means of surgically implanted, chronic catheters. Plasma samples were collected and analyzed by radioimmunoassay (RIA). Salmon calcitonin PK were evaluated using 2-compartmental and model independent methods. Intravenous sCT PK were non-linear over the dose range studied. High dose groups (100-1000 microg) demonstrated higher total plasma clearance (CL) and V(dss) than the low dose groups (1-25 microg). However, the MRT did not change for doses ranging from 10 to 1000 microg. After SC administration, the absorption of sCT was rapid with bioavailability (BA) varying from 21.4 to 52.9%. However, the BA of sCT was low after ID, IL, and IC administration (0.039, 0.064, and 0.021%, respectively). The role of hepatic first-pass elimination was negligible. The results of these studies demonstrate that the elimination of sCT is rapid but does not occur in the liver. Enhanced sCT clearance at higher doses was indicated by increasing V(dss) values, and it is hypothesized that increased renal blood flow and/or saturated plasma protein binding may contribute to the non-linear behavior. The IVAP canine model was found to have utility for probing the absorption and disposition PK of sCT. The combination of high oral bioavailability variability and non-linear disposition of sCT may produce highly variable therapeutic effects. The practical impact of the non-linear disposition of sCT remains to be determined. Based on the current results it appears that the rate-limiting step to the successful oral administration of sCT is its delivery into the portal vein since hepatic metabolism was negligible.
Y Hee Lee; G D Leesman; V Makhey; H Yu; P Hu; B Perry; J P Sutyak; E J Wagner; L M Falzone; W Stern; P J Sinko
Related Documents :
11949878 - Pharmacokinetics of paeoniflorin after oral administration of shao-yao gan-chao tang in...
23358 - Bioavailability of digoxin: some pitfalls and problems.
24714118 - Reversal of dabigatran-induced bleeding by coagulation factor concentrates in a rat-tai...
12736498 - Pharmacokinetics of (-)-epicatechin-3-o-gallate, an active component of onpi-to, in rats.
22955648 - Effects of titanium mesh implant on dosimetry during gamma knife radiosurgery.
16731788 - Obstetric and neonatal outcomes to recombinant porcine somatotropin administered in the...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V     Volume:  50     ISSN:  0939-6411     ISO Abbreviation:  Eur J Pharm Biopharm     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-09-28     Completed Date:  2000-09-28     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  9109778     Medline TA:  Eur J Pharm Biopharm     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  205-11     Citation Subset:  IM    
Department of Pharmaceutics, Rutgers University, College of Pharmacy, Piscataway, NJ 08854, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Calcitonin / pharmacokinetics*
Dose-Response Relationship, Drug
Intestinal Absorption*
Liver / metabolism*
Skin Absorption
Reg. No./Substance:
47931-85-1/salmon calcitonin; 9007-12-9/Calcitonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Improvement of intestinal absorption of peptides: adsorption of B1-Phe monoglucosylated insulin to r...
Next Document:  Enhancement of oral absorption of metronidazole suspension in humans.